Micro-scaled method holds promise as improved cancer diagnostic platform

A new method analyzes the combination of tumor genetic material (genomics) with deep protein and phosphoprotein characterization (proteomics) using a single-needle core biopsy from a patient's tumor, providing more detailed information about the cancer than conventional approaches.